RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer.

Xie, Shi-Yang; Li, Guang; Han, Chong; Yu, Yang-Yang; Li, Nan

Xie, Shi-Yang; Li, Guang; Han, Chong; Yu, Yang-Yang; Li, Nan.

Afiliación

Xie SY; Department of Radiation Oncology, The First Affiliated Hospital of Chi Medical University, Shenyang, China.
Li G; Department of Radiation Oncology, The First Affiliated Hospital of Chi Medical University, Shenyang, China.
Han C; Department of Radiation Oncology, The First Affiliated Hospital of Chi Medical University, Shenyang, China.
Yu YY; Department of Radiation Oncology, The First Affiliated Hospital of Chi Medical University, Shenyang, China.
Li N; Department of Radiation Oncology, The First Affiliated Hospital of Chi Medical University, Shenyang, China.

Onco Targets Ther ; 10: 5605-5619, 2017.

Article en En | MEDLINE | ID: mdl-29200875

Palabras clave

CSCs; NSCLC; RKIP; Shh signaling pathway; radiosensitivity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google